Refractory neurosarcoidosis responding to infliximab

被引：81

作者：

Pettersen, JA

Zochodne, DW

Bell, RB

Martin, L

Hill, MD

机构：

[1] Univ Calgary, Foothills Hosp, Dept Clin Neurosci, Calgary, AB T2N 2T9, Canada

[2] Univ Calgary, Foothills Hosp, Dept Med, Calgary, AB T2N 2T9, Canada

[3] Univ Calgary, Foothills Hosp, Dept Community Hlth Sci, Calgary, AB T2N 2T9, Canada

来源：

关键词：

D O I：

10.1212/01.WNL.0000034766.13282.33

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1660 / 1661

页数：2

共 7 条

[1] Baughman RP, 2001, SARCOIDOSIS VASC DIF, V18, P70
[2] Baughman RP, 1997, SARCOIDOSIS VASC DIF, V14, P121
[3] BAUGHMAN RP, 1990, J LAB CLIN MED, V115, P36
[4] NEVILLE E, 1983, Q J MED, V208, P525
[5] Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-α therapy
Yee, AMF
Pochapin, MB
[J]. ANNALS OF INTERNAL MEDICINE, 2001, 135 (01) : 27 - 31
[6] Central nervous system sarcoidosis - diagnosis and management
Zajicek, JP
Scolding, NJ
Foster, O
Rovaris, M
Evanson, J
Moseley, IF
Scadding, JW
Thompson, EJ
Chamoun, V
Miller, DH
McDonald, WI
Mitchell, D
[J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 1999, 92 (02) : 103 - 117
[7] Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers
Ziegenhagen, MW
Benner, UK
Zissel, G
Zabel, P
Schlaak, M
MullerQuernheim, J
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (05) : 1586 - 1592